Trademark Clearinghouse passes 5,000 registrations

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Trademark Clearinghouse passes 5,000 registrations

Cosmetics and pharmaceutical companies have not yet made extensive use of Icann’s Trademark Clearinghouse, which can help to protect brands from cybersquatting in the new gTLDs

According to information published today, there have so far been 5,000 registrations in the Clearinghouse.

But only 1% of marks relate to cosmetics, and just 0.8% cover pharmaceutical and medical products.

Less than 10% of the marks in the Clearinghouse so far relate to clothing and footwear, while 23% are for scientific or teaching apparatus, 22% for advertising or business management and 16% relate to sporting equipment.

The breakdown of marks is based on the Nice classification.

The US is the biggest source of Clearinghouse applications, making up 44%. France accounts for 10%, the UK for 7% and Germany for 4%.

Almost two-third of the records are registered for only one year.

Icann is holding a public meeting in Durban, South Africa this week at which further discussions on the gTLD rollout and other IP protection mechanisms are taking place.

Yesterday, Icann signed four new gTLD agreements, all of them with operators of TLDs in non-western scripts.

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article